Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Post by mfran91on Aug 06, 2020 6:46pm
335 Views
Post# 31376100

Is this not an overreaction due to impatience?

Is this not an overreaction due to impatience?Can someone please explain today's movement to me, what happened today doesn't make sense. There were no material changes with the company at all. Obviously any kind of delay or pushout is negative news but does that really warrant a 40% drop especially if it's not due to negligence or underperformance on the part of the company? FDA released new evaluation protocols so Sona has to make adjustments - I do not understand why that would cause a drop so dramatic. 

Key thing here is patience now. The fact is they have to most accurate antigen test on the market and have been taking all the right steps to bring it to market. Holding on to my shares and may even look to add more at open, 2 weeks is not a long time to wait at all...
<< Previous
Bullboard Posts
Next >>